CAJ | 학술논문

观察参芪活血利水方对冠心病慢性心衰患者脑钠肽(BNP)和6分钟步行试验(6MWT)的影响.86例冠心病慢性心衰患者随机分为对照组(西药常规治疗)和治疗组(西药常规治疗+参芪活血利水方),治疗四周后,检测患者BNP和6MWT的变化情况.结果与对照组相比较,治疗组的BNP水平明显降低,6MWT距离明显延长,差异有非常显著性(P<0.01).结论参芪活血利水方可以降低冠心病慢性心衰患者BNP含量,增强患者运动耐量,从而提高患者生活质量.
관찰삼기활혈이수방대관심병만성심쇠환자뇌납태(BNP)화6분종보행시험(6MWT)적영향.86례관심병만성심쇠환자수궤분위대조조(서약상규치료)화치료조(서약상규치료+삼기활혈이수방),치료사주후,검측환자BNP화6MWT적변화정황.결과여대조조상비교,치료조적BNP수평명현강저,6MWT거리명현연장,차이유비상현저성(P<0.01).결론삼기활혈이수방가이강저관심병만성심쇠환자BNP함량,증강환자운동내량,종이제고환자생활질량.
To observe effect of Shen-Qi-Huo-Xue-Li-Shui prescription (SQHXLSp) on brain natriurefic peptid (BNP) and 6-minute walking test (6MWT) of patients with coronary artery heart disease (CHD) and chronic heart failure (CI-LF). 86 patients with CHD and CHF were divided randomly into control group (42 cases) and treat group (44 cases). Patients in control group would be treated western medicine: patients in treat group would be treated western medicine and SQHXLSp. After the treatment of 4 weeks, we would detect the contents of BNP and 6MWT of patients with CHD and CHF. The results showed : Compared with control group, there were extremely significant difference about BNP and 6MWT of treat group (P<0.01) .Conclusion SQHXLSp could reduce the content of BNP in patients with CHD and CHF, to improve their exercise tolerance and the quality of life.